- Alcami a leading contract development and manufacturing organisation and CDMO Live partner, have announced a partnership with Tanvex CDMO.
- The collaboration offers a complete solution from bulk drug substance production to finished drug product and aims to expedite the delivery of sterile injectables to patients.
Alcami Corporation has announced a new partnership with Tanvex CDMO, a biologics developer offering pre-clinical to commercial biologic CDMO services.
Through this collaboration, Alcami and Tanvex can now offer clients a complete solution from bulk drug substance production through to finished drug product. This partnership pairs Alcami’s expertise in liquid and lyophilisation sterile filling, packaging, and labeling with Tanvex’s high-throughput bulk drug substance development and manufacturing services.
“We are delighted to work alongside the team at Tanvex, as our organizations share a commitment to helping clients overcome development and manufacturing obstacles during this unprecedented demand for complex biologics and specialty therapeutics,” said Alcami CEO Bill Humphries. “By delivering unrivaled expertise in high-quality fill-finish operations and leveraging our combined 60 years of expertise and close working relationship, I’m confident that together we will expedite the delivery of sterile injectables to patients, which is the critical outcome we’re all seeking.”
“Tanvex is excited to announce our partnership with the team at Alcami. With our complementary services and shared client focus, this collaboration will expand our high-quality service offering for our mutual clients,” said John Mosack, Tanvex Chief Operating Officer.
“By combining our deep biologics development and manufacturing expertise, we expect the relationship will expedite the biologics drug development and manufacturing timeline for our clients.”
Alcami is a contract development and manufacturing organization headquartered in North Carolina with over 40 years of experience advancing products through every stage of the development lifecycle with over 675,000 ft² across the United States.
 Overview of outsourcing trends 
